Psychiatry Medical News about Gender; depression; antidepressants

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Omega-3 fatty acids for bipolar disorder

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Are there differences between serotonergic, noradrenergic and dual acting antidepressants in the treatment of depressed women?
World Journal of Biological Psychiatry, 08/17/09

Eker SS et al. – These results suggest that noradrenergic and serotonergic activity do not differ from each other in treating depressed women. However, serotonergic activity appears to be more prominent in some particular symptoms such as feelings of guilt, suicidal ideation and sleep. Also, menopause does not appear to affect antidepressants' benefit in depressed women.

Methods

Data of the 111 depressed women who were included and completed the previous four open-label studies where patients were evaluated six times during a 10-week period, were pooled in the current study.
Each of the reboxetine, sertraline and venlafaxine groups consisted of 37 depressed women.
Patients were also divided into two subgroups of age, determining the 44 years as the cut-off point representing the menopausal status.

Results

No significant difference was observed in the percent change of Hamilton Depression Rating Scale-17 (HDRS) and remission rates among treatment groups.
Percent changes in Clinical Global Impression-Severity of Illness scale (CGI-S) and response rates were in favour of venlafaxine group at week 10
Individual HDRS items 2, 3, 4, 5 and 6 demonstrated significant improvement in the sertraline group, whereas HDRS item 7 demonstrated significant improvement in the venlafaxine group.
An early reduction in anxiety subscale was observed in the venlafaxine group. Menopausal status had no impact on the outcome measures.

<< Previous
Smoking cessation during alcohol treatment: a randomized trial of...

Next >>
Randomized controlled trial of interventions for young people at...

Gender Differences in Food Preferences of School-Aged Children and Adolescents
Journal of School Health, 10/20/09 Relevance Score: 89%

Gender moderates the health-effects of job strain in managers
International Archives of Occupational & Environmental Health, 11/09/09 Relevance Score: 88%

Heart Attack Symptoms: Closing the Gender Gap
Ivanhoe, 10/28/09 Relevance Score: 87%

Contribution of Glucose Tolerance and Gender to Cardiac Adiposity
Journal of Clinical Endocrinology and Metabolism, 10/15/09 Relevance Score: 87%

Gender Differences in Alcohol Impairment of Simulated Driving Performance and Driving-Related Skills
Alcohol and Alcoholism, 10/02/09 Relevance Score: 87%